Tools for Practice Outils pour la pratique


#281 Hindsight: Top 5 Tools for Practice of 2020


CLINICAL QUESTION
QUESTION CLINIQUE
What were the top 5 Tools for Practice of 2020?


BOTTOM LINE
RÉSULTAT FINAL
  1. What is the diagnostic accuracy of primary care physicians performing virtual visits compared to in-person visits for undifferentiated presentations?
  2. In type 2 diabetes, do dipeptidyl peptidase-4 (DPP-4) inhibitors improve patientoriented outcomes like cardiovascular disease (CVD)?
  3. What is the chance of obtaining an incorrect result with the polymerase chain reaction (PCR) test for COVID-19?
  4. Is exercise effective for hip/knee osteoarthritis pain management?
  5. To prevent gout recurrence, should we dose urate lowering therapies (like allopurinol) to target uric acid levels?



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
1. What is the diagnostic accuracy of primary care physicians performing virtual visits compared to in-person visits for undifferentiated presentations?
  • Bottom Line: Based on limited, lower-level evidence, diagnostic accuracy of virtual visits was between 71-91%, measured using standardized patients or case review at 3 months. Diagnostic accuracy/agreement of virtual care seems similar to in-person visits. These studies do not address continuity of care or patient outcomes.
2. In type 2 diabetes, do dipeptidyl peptidase-4 (DPP-4) inhibitors improve patientoriented outcomes like cardiovascular disease (CVD)?
  • Bottom Line: DPP-4 inhibitors have no effect on patient-oriented outcomes like CVD (example myocardial infarction or stroke) or death. They increase the risk of hypoglycemia, pancreatitis and likely heart failure hospitalization. The choice for second line therapy after metformin should focus on drugs that reduce the risk of CVD (ie. SLGT-2 inhibitors or GLP-1 agonists).
3. What is the chance of obtaining an incorrect result with the polymerase chain reaction (PCR) test for COVID-19?
  • Bottom Line: If the PCR COVID-19 test is positive you have COVID-19 (specificity ~100%). Small Canadian studies suggest the test will detect COVID-19 ~80-90% of the time (sensitivity), although estimates range from ~50%-90%. Collection technique, anatomical sample and timing of collection influence these numbers. The chance of a false negative depends on sensitivity and the pre-test probability. Example: someone with abnormal chest x-rays and close COVID-19 positive contacts has a higher risk of false negatives than someone who is asymptomatic.
4. Is exercise effective for hip/knee osteoarthritis pain management?
  • Bottom Line: In adults with knee or hip osteoarthritis, exercise can lead to ~30% pain improvement for 47% of patients versus 21% with no exercise at 6-104 weeks, benefiting one additional person for every 4 treated. The type of exercise does not significantly affect the results, however most included trials utilized physiotherapy.
5. To prevent gout recurrence, should we dose urate lowering therapies (like allopurinol) to target uric acid levels?
  • Bottom Line: Best evidence finds that increasing doses of allopurinol to achieve a specific serum urate target (example <360 μmol/L) does not reduce gout flares, pain, or function, compared to standard allopurinol dosing. Febuxostat increases cardiovascular and overall mortality and should not be used in most patients with gout.


Bridget Picco March 5, 2021

Very useful

Bridget Picco March 5, 2021

Excellent information

Michel Cauchon April 17, 2021

treat to target to prevent recurrence: discordant evidence?

Emad Henein June 27, 2021

Useful and practical information.


Latest Tools for Practice
Derniers outils pour la pratique

#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
Read Lire 0.25 credits available Crédits disponibles

#377 How to slow the flow IV: Combined oral contraceptives

In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
Read Lire 0.25 credits available Crédits disponibles

#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)

What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • PEER Team

1. Sept L, Kirkwood J, Korownyk C. Virtual visits versus face-to-face: diagnostic accuracy in primary care. Tools for Practice #273 online publication. Published September 21, 2020. Available at: https://gomainpro.ca/wp-content/uploads/toolsfor-practice/1601913617_tfp273virtualvisits.pdf Accessed 20-NOV-2020.

2. Moe S, Allan GM. DPP-4 inhibitor update: Thousands studied but still no evidence of clinical benefits. Tools for Practice #250 online publication. Published January 6, 2020. Available at: https://gomainpro.ca/wp-content/uploads/tools-forpractice/1578510344_tfp250dpp4updatefv.pdf Accessed 20-NOV-2020

3. Korownyk C, McCormack J. Finding COVID - How Good is the Test to Detect it? Tools for Practice #263 online publication. Published May 21, 2020. Available at: https://gomainpro.ca/wp-content/uploads/tools-forpractice/1589994222_tfp263_sensitivityofcovidtestfv.pdf Accessed 25-NOV-2020

4. Perry D, Ton J, Korownyk C. Exercise for osteoarthritis pain: how strong is the evidence? Tools for Practice #255 online publication. Published March 16, 2020. Available at: https://gomainpro.ca/wp-content/uploads/tools-forpractice/1584370190_tfp255-exerciseforoa.pdf Accessed 25-NOV-2020.

5. Ton J, Kolber MR. Who let the Gout Out? Targeting Uric Acid Levels in Treating Gout. Tools for Practice #262 online publication. Published May 19, 2020. Available at: https://gomainpro.ca/wp-content/uploads/tools-forpractice/1589571963_tfp262allopurinolfv.pdf Accessed 25-NOV-2020.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.